Connect with us

Health

Researchers identify potential combination therapy for aggressive lung cancer – Medical Xpress

A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center has identified a novel combination therapy to potentially help overcome resistance to…

Published

on

Article feature image

A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center has identified a novel combination therapy to potentially help overcome resistance to immunotherapy in people diagnosed with advanced lung cancer. The combination approach uses immune checkpoint inhibitors with ATRA, a safe medication that is widely used to treat leukemia. The team found the combination therapy led to eradication of over 70% of tumors when tested in mice with LKB1-deficient lung cancer. It also generated…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Mayo Clinic trial signals potential for AI-guided heart disease detection – Healthcare IT News
Article feature image
Gene Tied to Balding May Also Raise COVID Risks for Men – HealthDay News